UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nitric Oxide: A New Paradigm for Second Messengers

Journal of medicinal chemistry, 1995-10, Vol.38 (22), p.4343-4362

1995

Volltextzugriff (PDF)

Game-based training of flexibility and attention improves task-switch performance: near and far transfer of cognitive training in an EEG study

Psychological research, 2018-01, Vol.82 (1), p.186-202

2018

Volltextzugriff (PDF)

The arginine-nitric oxide pathway: A target for new drugs

Medicinal research reviews, 1994-01, Vol.14 (1), p.23-74

1994

Volltextzugriff (PDF)

N ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation

European journal of pharmacology, 1990-02, Vol.176 (2), p.219-223

1990

Volltextzugriff (PDF)

Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation

Journal of neuroscience research, 1992-09, Vol.33 (1), p.129-135

1992

Volltextzugriff (PDF)

Nitroaromatic Amino Acids as Inhibitors of Neuronal Nitric Oxide Synthase

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2636-2642

1998

Volltextzugriff (PDF)

Subtypes of Sodium‐Dependent High‐Affinity L‐[3H]Glutamate Transport Activity: Pharmacologic Specificity and Regulation by Sodium and Potassium

Journal of neurochemistry, 1993-01, Vol.60 (1), p.167-179

1993

Volltextzugriff (PDF)

Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH)

Journal of medicinal chemistry, 2000-04, Vol.43 (8), p.1586-1603

2000

Volltextzugriff (PDF)

Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase

The Journal of pharmacology and experimental therapeutics, 1991-01, Vol.256 (1), p.38

1991

Volltextzugriff (PDF)

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)

Molecular pharmacology, 1989-12, Vol.36 (6), p.881-886

1989

Volltextzugriff (PDF)

Cholecystokinin (CCK) antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors

Journal of medicinal chemistry, 1991-12, Vol.34 (12), p.3350-3359

1991

Volltextzugriff (PDF)

Evidence that type A CCK receptors facilitate dopamine efflux in rat brain

European journal of pharmacology, 1988-08, Vol.152 (3), p.371-372

1988

Volltextzugriff (PDF)

Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists

Journal of medicinal chemistry, 1989-04, Vol.32 (4), p.739-742

1989

Volltextzugriff (PDF)

N omega-nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells

Canadian journal of physiology and pharmacology, 1990-06, Vol.68 (6), p.749

1990

Volltextzugriff (PDF)

Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity

The Journal of pharmacology and experimental therapeutics, 1998-05, Vol.285 (2), p.628

1998

Volltextzugriff (PDF)

Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor

Pharmacology, biochemistry and behavior, 1989-12, Vol.34 (4), p.779-783

1989

Volltextzugriff (PDF)

Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin

The Journal of pharmacology and experimental therapeutics, 1997-08, Vol.282 (2), p.891

1997

Volltextzugriff (PDF)

Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs

Pharmacology, 1996-12, Vol.53 (6), p.356-368

1996

Volltextzugriff (PDF)

Spirituality and Psychological Adaptation Among Women With HIV/AIDS: Implications for Counseling

Journal of counseling psychology, 2002-04, Vol.49 (2), p.139-147

2002

Volltextzugriff (PDF)

EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells

Advances in second messenger and phosphoprotein research, 1990, Vol.24, p.441

1990

Volltextzugriff (PDF)

Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors

The Journal of pharmacology and experimental therapeutics, 1996-05, Vol.277 (2), p.885

1996

Volltextzugriff (PDF)

Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro

Journal of receptors and signal transduction, 1995-09, Vol.15 (7-8), p.863-885

1995

Volltextzugriff (PDF)

Methodology for the preparation of N-guanidino-modified arginines and related derivatives

Journal of organic chemistry, 1993-07, Vol.58 (16), p.4331-4338

1993

Volltextzugriff (PDF)

Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia

Journal of medicinal chemistry, 2001-06, Vol.44 (12), p.1971-1985

2001

Volltextzugriff (PDF)

[3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin

European journal of pharmacology, 1997-05, Vol.327 (1), p.79-86

1997

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(377)
Mit Volltextzugriff
(344)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nitric Oxide: A New Paradigm for Second Messengers

Game-based training of flexibility and attention improves task-switch performance: near and far transfer of cognitive training in an EEG study

The arginine-nitric oxide pathway: A target for new drugs

N ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation

Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation

Nitroaromatic Amino Acids as Inhibitors of Neuronal Nitric Oxide Synthase

Subtypes of Sodium‐Dependent High‐Affinity L‐[3H]Glutamate Transport Activity: Pharmacologic Specificity and Regulation by Sodium and Potassium

Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH)

Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)

Cholecystokinin (CCK) antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors

Evidence that type A CCK receptors facilitate dopamine efflux in rat brain

Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists

N omega-nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells

Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity

Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor

Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin

Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs

Spirituality and Psychological Adaptation Among Women With HIV/AIDS: Implications for Counseling

EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells

Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors

Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro

Methodology for the preparation of N-guanidino-modified arginines and related derivatives

Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia

[3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin

Suchergebnisse filtern